CN108872576A - A kind of chemical luminescence immune analysis reagent box for Seneca Valley virus nonstructural protein 3A BC antibody test - Google Patents

A kind of chemical luminescence immune analysis reagent box for Seneca Valley virus nonstructural protein 3A BC antibody test Download PDF

Info

Publication number
CN108872576A
CN108872576A CN201810765363.2A CN201810765363A CN108872576A CN 108872576 A CN108872576 A CN 108872576A CN 201810765363 A CN201810765363 A CN 201810765363A CN 108872576 A CN108872576 A CN 108872576A
Authority
CN
China
Prior art keywords
seneca valley
valley virus
serum
reagent box
nonstructural protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810765363.2A
Other languages
Chinese (zh)
Inventor
吕建亮
潘丽
张中旺
张永光
卢田鑫
李姚尧
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lanzhou Veterinary Research Institute of CAAS
Original Assignee
Lanzhou Veterinary Research Institute of CAAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lanzhou Veterinary Research Institute of CAAS filed Critical Lanzhou Veterinary Research Institute of CAAS
Priority to CN201810765363.2A priority Critical patent/CN108872576A/en
Publication of CN108872576A publication Critical patent/CN108872576A/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • G01N33/56994Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/76Chemiluminescence; Bioluminescence
    • G01N21/763Bioluminescence
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/535Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01DNA viruses
    • G01N2333/03Herpetoviridae, e.g. pseudorabies virus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plasma & Fusion (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention discloses a kind of chemical luminescence immune analysis reagent boxes for Seneca Valley virus nonstructural protein 3A BC antibody test.The kit includes chemiluminescence immune assay plate, positive control serum, negative control sera, enzyme labelled antibody, sample diluting liquid, Chemoluminescent substrate, luminescence enhancer and the concentrated cleaning solution of Seneca Valley virus nonstructural protein 3A BC antigen coat.The amino acid sequence of the Seneca Valley virus nonstructural protein 3A BC is as shown in SEQ ID NO.2.Kit of the present invention uses the nonstructural protein 3A BC antigen coat reaction plate of prokaryotic expression, antigen dosage is few, it can efficiently detect with the presence or absence of Seneca Valley virus in Swine serum, and not reacted with pig blisters poison, swine fever virus and -2 type of pig circular ring virus.Determined using enzyme-catalyzed chemical luminescence reaction system as a result, improving detection sensitivity.Kit specificity of the present invention is good, sensitive, efficient, has good market prospects.

Description

A kind of chemiluminescence for Seneca Valley virus nonstructural protein 3A BC antibody test Immunoassay kits
Technical field
The present invention relates to a kind of chemiluminescence immunoassays for Seneca Valley virus nonstructural protein 3A BC antibody test point Kit is analysed, the application method of the kit is further related to.The invention belongs to technical field of virus detection.
Background technique
Pig Sai Nika paddy disease is that a boar caused by Seneca Valley virus (Seneca Valley virus, SVV) is primary Property blister sore.The disease mainly causes pig mouth and nose mucous membrane and hoof bubble and ulcer occur.2008 and 2012, the U.S. added and takes Big that some areas is waited to be diagnosed to be SVV, in September, 2015 in morbidity swinery, there is cyllopodia, bubble and companion in certain pig farm swinery of the U.S. With newborn piglet death, PCR detection exclude foot and mouth disease virus (FMDV), Porcine epidemic diarrhea virus (PEDV), porcine rotavirus, The infection of transmissible gastro-enteritis virus (TGEV) and pig breathing and breeding syndrome viral (PRRSV), serum, the skin of morbid pig Skin, excrement, hoof coronary band PCR testing result be shown as SVV the positive, be finally diagnosed as Seneca Valley virus infection.Together Year, blister disease occurs in succession for Guangdong Province of China pig farm, and sow fever anorexia, mouth and nose and hoof bubble occur, propagate speed Degree is fast, and is feminine gender through detection FMD, SVD, VS testing result, SVV is shown as positive, then with delivery room piglet acute death One plant of Seneca Valley virus strain (CH-01-2015) is isolated, this is that first Chinese report has pig to infect SVV.Although pig plug Buddhist nun, which blocks paddy disease, not will cause heavy economic losses identical with foot and mouth disease virus, but the disease also have for newborn piglet it is higher Lethality, clinical symptoms and aftosa, swine pox, vesicular stomatitis etc. are highly similar, bring to identifying and distinguishing the disease Certain difficulty, currently, there is no effective vaccine and diagnostic reagent for prevention and control SVV.Therefore, develop corresponding vaccine and Antidiastole reagent is of great significance to prevent and diagnose pig Sai Nika paddy disease.
SVV full-length genome about 7.2kb, including 5 '-U TR, 3 '-UTR, 1 open reading frame (ORF) and 3 ' ends Poly (A) tail, studies have shown that the RNA of SVV encodes the polyprotein of 1 a length of 2181 amino acid, which can be into one One-step hydrolysis is leader protein L, structural proteins P1, and non-structural protein P2 and P3, P1 are further had albumen in P3 precursor protein The 3C of enzymatic activity and some possible cell restriction endonuclease cuttings are decomposed into tri- kinds of structural proteins of VP0, VP1 and VP3.For pig plug Buddhist nun For the diagnosis for blocking paddy disease, detects non-structural protein or its antibody can effectively distinguish vaccine immunity animal and wild virus infection is dynamic Object.
Chemiluminescence immunoassay technology (chemiluminescence immunoassay, CLIA) is that will have Gao Ling The chemical luminescent detecting technology of sensitivity is combined with the immune response of high specific, for various antigens, haptens, antibody, is swashed The detection and analysis technology of element, enzyme, fatty acid, vitamin and drug etc..It is to exempt from analysis, fluoroimmunoassay after radioimmunology analysis, enzyme With the newest immunoassay to grow up after time-resolved fluoroimmunoassay.Chemiluminescence immune assay it is quick Perception and signal-to-noise ratio are high, and background fluorescence signal is low, and the analyte of extremely low concentration can be detected in the very wide range of linearity, can By extensively being applied many advantages, such as luminometer device quantitative analysis test sample in each field of life science, such as detect AIDS virus, hepatitis type B virus, detection tumor marker etc..Currently the chemiluminescence about the diagnosis of pig Sai Nika paddy disease is exempted from Epidemic disease analysis method has not been reported.
The present invention is using Seneca Valley virus nonstructural protein 3A BC as candidate gene, and clone obtains 3ABC gene, with big It is expressed in enterobacteria and purifies 3ABC albumen as envelope antigen, establish the chemistry hair of the rapid differential diagnosis of Seneca Valley virus Light immunoassay kits is maked a good technical reserve in advance for the possibility epidemic situation for coping with Seneca Valley virus from now on important meaning Justice.
Summary of the invention
The purpose of the present invention is to provide a kind of detection time is short, specificity is good, high sensitivity for Sai Nika paddy disease The chemical luminescence immune analysis reagent box of malicious nonstructural protein 3A BC antibody test.It aims to solve the problem that in above-mentioned background technique, at present The problem of there is no prevention and control of effective, the quick antidiastole reagent for Seneca Valley virus, for Buddhist nun is filled in reply in advance from now on The possibility epidemic situation of card paddy virus make a good technical reserve.
To achieve the goals above, present invention employs following technological means:
The present invention provides a kind of chemiluminescence immunoassay for Seneca Valley virus nonstructural protein 3A BC antibody test point Kit is analysed, the kit includes the chemiluminescence immune assay of Seneca Valley virus nonstructural protein 3A BC antigen coat Plate, positive control serum, negative control sera, enzyme labelled antibody, sample diluting liquid, Chemoluminescent substrate, luminescence enhancer with And concentrated cleaning solution.
Wherein, it is preferred that the Seneca Valley virus nonstructural protein 3A BC antigen is obtained through prokaryotic expression system, ammonia Base acid sequence is as shown in SEQ ID NO.2.
Wherein, it is preferred that the chemiluminescence immunoassay of the Seneca Valley virus nonstructural protein 3A BC antigen coat point Analysis plate is prepared in accordance with the following methods:
(1) preparation and coating of envelope antigen
The recombinant protein inclusion body that prokaryotic expression obtains purifies to obtain Sai Nika paddy disease through renaturation and Ni-NTA Malicious nonstructural protein 3A BC, amino acid sequence are diluted to 2.5 μ with carbonate buffer solution when coating as shown in SEQ ID NO.2 G/ml, according in the coating to chemiluminescence immune assay plate of 100 holes μ l/, 4 DEG C of refrigerators are stood overnight;
(2) closing and preservation of chemiluminescence immune assay plate
Chemiluminescence immune assay plate with PBST washing 3 times, every hole be added 100 μ l contain 5w/v% skimmed milk power and The confining liquid of 0.01w/v% thimerosal, 37 DEG C of closing 2h discard confining liquid, and PBST is washed 3 times, using aluminium foil bag vacuum seal, 4 DEG C of preservations.
Wherein, it is preferred that the positive control serum is 14 days after Seneca Valley virus infects high infection titers Swine serum;The negative control sera is the healthy Swine serum that any vaccine was not immunized.
Wherein, it is preferred that the enzyme labelled antibody is the rabbit-anti pig IgG secondary antibody of horseradish peroxidase-labeled.
Wherein, it is preferred that the sample diluting liquid is trehalose containing 1w/v%, 0.01w/v% thimerosal, 0.01v/ The 0.01M phosphate solution of v%Tween20 and 0.5w/v% casein.
Wherein, it is preferred that the Chemoluminescent substrate is with Tris-HCl buffer containing luminol and right The mixed liquor of iodophenol, the luminescence enhancer are with Tris-HCl buffer containing hydrogen peroxide and Tween20 Mixed liquor.It is furthermore preferred that the Chemoluminescent substrate is to contain 0.1mmol/L with 0.05M Tris-HCl buffer To the mixed liquor of iodophenol, the luminescence enhancer is to be matched with 0.05M Tris-HCl buffer by luminol and 0.1mmol/L The mixed liquor of the hydrogen peroxide containing 7.5mmol/L of system, the Tween20 that volume fraction is 0.005%.
Wherein, it is preferred that the concentrated cleaning solution is 10 × PBST solution, i.e., containing 0.5v/v%Tween20's 0.1mol/LPBS solution, pH 7.4 dilute 10 times when use.
Further, the invention also provides carry out Seneca Valley virus nonstructural protein 3A BC using the kit The method of antibody test, follows the steps below:
(1) Sample Dilution
By sample to be tested, positive control serum and negative control sera sample diluting liquid according to volume ratio 1:32 carry out Dilution;
(2) board-washing
The chemiluminescence immune assay of Seneca Valley virus nonstructural protein 3A BC antigen coat is taken out from 4 DEG C of refrigerators Plate opens aluminium foil bag, takes out chemiluminescence immune assay plate, with cleaning solution board-washing 3 times diluted, blotting paper is patted dry, every time 3min;
(3) it is loaded
Sample to be tested, positive control serum and negative control sera after dilution is separately added into chemiluminescence immunoassay point It analyses in plate, every hole 100 μ L, 37 DEG C of incubation 5min;
(4) it washs
Chemiluminescence immune assay plate is taken out, blood serum sample is got rid of, is rinsed 4 times with cleaning solution, blotting paper pats dry;
(5) enzyme labelled antibody is added
The rabbit-anti pig IgG secondary antibody of the horseradish peroxidase-labeled diluted, 100 holes μ L/, 37 DEG C of work 5min are added;
(6) add substrate:
Enzyme labelled antibody is got rid of, is rinsed 4 times with cleaning solution, blotting paper pats dry, chemiluminescent substrate and luminescence enhancer is added, It mixes, is protected from light and stands 5min;
(7) luminous value, calculating and judgement are measured:
In measuring luminous value on chemical illumination immunity analysis instrument device, all samples to be tested are indicated with percent positive (positive percent, PP), reduction formula is as follows:
PP=(sample to be tested luminous value-negative control sera average irradiance) × 100%/(positive control serum is average Luminous value-negative control sera average irradiance)
Critical value is set to 7.27%, and the positive is determined as if calculated result >=7.27%, otherwise is feminine gender.
Compared to the prior art, the beneficial effects of the present invention are:
(1) detection kit of the present invention is by Seneca Valley virus nonstructural protein 3A BC in E.Coli high efficient expression, egg White yield is high, and antigen purity is up to 90% or more;
(2) this kit is determined using enzyme-catalyzed chemical luminescence reaction system as a result, improving detection sensitivity;
(3) chemiluminescence immune analysis method currently about the diagnosis of Sai Nika paddy disease has not been reported, present invention detection Kit has the advantages that easy to operate, detection time is short, and sensibility is high, high specificity, can be used for a large amount of sample detections and Epidemiological survey.
Detailed description of the invention
Fig. 1 is 3ABC protein expression result provided in an embodiment of the present invention;
In figure:Swimming lane M:Protein Marker (116.0/66.2/45.0/35.0/25.0/18.4/14.4kDa);Swimming Road 1:Host strain whole bacterial protein;Swimming lane 2:IPTG induces whole bacterial protein;
Fig. 2 is the bacterial cell disruption supernatant and precipitating SDS-PAGE electrophoresis of expression provided in an embodiment of the present invention;
In figure:Swimming lane M:Protein Marker (116.0/66.2/45.0/35.0/25.0/18.4/14.4kDa);Swimming Road 1:The broken supernatant protein of inducing expression;Swimming lane 2:The broken insoluble protein of inducing expression;
Fig. 3 is purification of recombinant proteins result provided in an embodiment of the present invention;
In figure:Swimming lane M:Protein Marker (116.0/66.2/45.0/35.0/25.0/18.4/14.4kDa);Swimming Road 1:Elute albumen.
Fig. 4 is the ROC analysis curve of 3ABC-CLIA provided in an embodiment of the present invention.
Specific embodiment
The present invention will be further described combined with specific embodiments below, but following embodiments will not limit in any way Protection scope of the present invention.
Embodiment 1 is used for the chemical luminescence immune analysis reagent box of Seneca Valley virus nonstructural protein 3A BC antibody test Preparation and assembling
(1) preparation of kit:
1, the expression of Seneca Valley virus nonstructural protein 3A BC antigen:
The encoding gene 969bp (shown in SEQ ID NO.1) of Seneca Valley virus nonstructural protein 3A BC is cloned into PET-30a (+) prokaryotic expression carrier, after digestion, sequencing are correct, positive plasmid is converted to BL21DE3plysS bacterial strain, blocks that Chloramphenicol resistance LB plate screening monoclonal, 37 DEG C, LB culture medium shakes bacterium and stays overnight;Bacterium solution (v/v) 1 by volume will be stayed overnight:100 turns It is connected to fresh LB, 37 DEG C, 200rpm shakes 3h and reaches 0.6 or so to OD600 value, and the IPTG of final concentration 1mmol/L is added Continue to shake bacterium 3h, bacterium solution is collected by centrifugation in 6000rpm.Cultivation temperature is reduced to 30 DEG C;IPTG inducer is added to final concentration 0.5mM, 30 DEG C of continuation shake culture 3-4h;8000rpm is centrifuged 3min and collects thallus, is resuspended in 50mL pre-cooling NTA-0 buffer In, ice bath 30min;Ultrasonication thallus, 4 DEG C of centrifugation 50min of 16000rpm collect supernatant and precipitating, take a small amount of supernatant and Precipitating carries out SDS-PAGE detection, and protein expression result is as shown in Figure 1.The bacterial cell disruption supernatant and precipitating SDS-PAGE electricity of expression Swimming figure is as shown in Figure 2.Remaining supernatant and precipitating be placed in 4 DEG C it is spare.
2, inclusion body protein purifying, renaturation:DTT to final concentration 1mM is added with the resuspension of 50mL NTA-0 buffer in precipitating, Ultrasound promotes foreign protein dissolution, and precipitating is collected by centrifugation, supreme clear bright in triplicate, and precipitating is resuspended with PBS, and ultrasound, centrifugation is gone Supernatant is resuspended inclusion body with 6M guanidine hydrochloride, adds DTT to final concentration 5mM;37 DEG C of concussion 3h are all dissolved to inclusion body, and centrifugation is gone Supernatant.Again with protein renaturation liquid by albumen low temperature dialysis renaturation, with the 3M guanidine hydrochloride diluted protein solution of 2 times of volumes, at 4 DEG C It being added dropwise in 200mL renaturation solution (pH8.0), rotational speed regulation to maximum, stirring for 24 hours, takes protein solution in bag filter, with With PBS buffer solution dialysed overnight after PEG60000 concentration.Albumen after renaturation is purified again with anion-exchange column Ni-NTA, is received Collect albumen.Protein purification result as shown in figure 3, Seneca Valley virus nonstructural protein 3A BC antigen amino acid sequence such as SEQ Shown in ID NO.2.
3, the selection of antigen coat and best peridium concentration:
Purified product through the prokaryotic expression carries out a series of 5 μ of dilutions with pH=9.6 carbonate buffer solution G/mL, 2.5 μ g/mL, 1.25 μ g/mL, 0.625 μ g/mL, 0.312 μ g/mL, each two column of concentration coating, 100 holes μ L/ are added to 96 On the chemiluminescence immune assay plate of hole, 4 DEG C of coatings are overnight.The result shows that envelope antigen concentration be 2.5 μ g/mL when P/N value most Greatly, the luminous value ratio about 160 with feminine gender positive at this time, it is thus determined that the concentration is best peridium concentration.
4, the closing of chemiluminescence immune assay plate:
Above-mentioned chemiluminescence immune assay plate PBST (the 0.01mol/LPBS solution containing 0.05v/v%Tween20, pH 7.4) it washes 4 times, 100 μ l confining liquids (thimerosal of 5w/v% skimmed milk power and 0.01w/v%), 37 DEG C of closing 2h are added in every hole. Discarding cleaning solution, PBST is washed 3 times, the chemiluminescence immune assay plate of pre-coated antigen is obtained, using aluminium foil bag vacuum seal, 4 DEG C of preservations.
5, the preparation of standard serum:
Susceptible piglet (the pig Seneca Valley virus serum of health of 70 ages in days is inoculated with according to immune programme with Seneca Valley virus Neutralize antibody titers are not higher than 1:4, pig Seneca Valley virus, porcine reproductive and respiratory syndrome virus, swine foot-and-mouth disease virus antigen It is negative), the Swine serum before acquisition inoculation is aseptic subpackaged as negative control sera by the batch sample, after in addition collecting inoculation 14 days serum, the batch sample is aseptic subpackaged as positive control serum.Standard serum is diluted with sample diluting liquid, dilution Ratio selects 1 respectively:8,1:16,1:32,1:64,1:128, result such as the following table 1 institute of luminous value is read using Chemiluminescence Apparatus Show.The result shows that when positive control serum serum dilution presses 1:When 32 dilution, P/N value is maximum, therefore the dilution is made For best serum dilution.
The sample diluting liquid is:Trehalose containing 1w/v%, 0.01w/v% thimerosal, 0.01v/v%Tween20 and The 0.01M phosphate solution of the casein of 0.5w/v%.
The chemiluminescence readings of the different serum dilutions of table 1
6, enzyme labelled antibody (10 ×)
The rabbit-anti pig IgG secondary antibody of horseradish peroxidase-labeled, 10 times of uses of dilution when use.
7、PBST(10×)
0.1mol/LPBS solution containing 0.5v/v%Tween20, pH 7.4.10 times of uses of dilution when use.
8, Chemoluminescent substrate
Iodophenol is mixed with the luminol containing 0.1mmol/L and 0.1mmol/L of 0.05M Tris-HCl buffer Close liquid.
9, luminescence enhancer
It is 0.005% with the hydrogen peroxide containing 7.5mmol/L of 0.05M Tris-HCl buffer, volume fraction The mixed liquor of Tween20.
(2) assembling and preservation of kit:
1, the assembling of kit:
According to kit contents listed by table 2, kit is assembled, is saved after composition loaded on 4 DEG C.
The content of 2 Seneca Valley virus chemical luminescence immune analysis reagent box of table
2, kit specification (detection method)
(1) it dilutes:PBST (10 ×) washing lotion is diluted to 250ml with aqua sterilisa, with sample diluting liquid by enzyme labelled antibody (10 ×) it is diluted to 5ml.
(2) board-washing:Aluminium foil bag is opened, the chemiluminescence immune assay plate of pre-coated antigen is taken out, with the PBST diluted Board-washing 3 times, blotting paper pats dry, each 3min.
(3) it is loaded:By test serum sample sample diluting liquid with 1:32 times of dilutions, every hole 100ul are added to reaction plate In, Seneca Valley virus positive control serum and negative control sera is added, with 1:32 times of dilutions, 100 holes μ L/, the control blood Two repetitions are done clearly.37 DEG C of effect 5min.
(4) it washs:Blood serum sample is got rid of, is rinsed 4 times with PBST, blotting paper pats dry;
(5) enzyme labeling antibody:The Ig G secondary antibody of the HRP- rabbit-anti pig diluted, 100 holes μ L/, 37 DEG C of work 5min are added.
(6) add substrate:Enzyme labelled antibody is got rid of, is rinsed 4 times with PBST, blotting paper pats dry.Chemiluminescent substrate A (50 μ are added The hole L/) and luminescence enhancer B (100 hole μ L/).It mixes, is protected from light and stands 5min.
(7) luminous value, calculating and judgement are measured:
In measuring luminous value on chemical illumination immunity analysis instrument device, all samples to be tested are indicated with percent positive (positive percent, PP), reduction formula is as follows:
PP=(sample to be tested luminous value-negative control sera average irradiance) × 100%/(positive control serum is average Luminous value-negative control sera average irradiance).
Critical value is set to 7.27%, and the positive is determined as if calculated result >=7.27%, otherwise is feminine gender.
Embodiment 2 is used for the chemical luminescence immune analysis reagent box of Seneca Valley virus nonstructural protein 3A BC antibody test Sensibility, specificity experiments
1, the dilution of known background serum:
(1) 30 parts of blood serum samples are shared from clinically healthy pig, these pigs did not infect Seneca Valley virus, this A little serum are used to evaluate the specificity of Seneca Valley virus non-structural protein antibody chemical luminescence detection method.
(2) pig blisters positive serum, swine fever virus positive serum and each 30 parts of -2 type positive serum of pig circular ring virus, this A little serum are used to evaluate the specificity of Seneca Valley virus nonstructural protein 3A BC antibody chemical luminescence detection method.
(3) 80 parts of blood serum samples are shared from the pig for experimentally attacking SVV.These pigs do not carry out before carrying out attacking poison It is any immune, and these blood serum samples are the blood serum samples collected after attacking poison.These serum are for evaluating Sai Nika paddy disease The sensibility of malicious nonstructural protein 3A BC antibody chemical luminescence detection method.
The above serum is diluted with sample diluting liquid, dilution ratio 1:32, the sample diluting liquid is:Seaweed containing 1w/v% The 0.01M phosphate solution of sugar, 0.01w/v% thimerosal, 0.01v/v%Tween20 and 0.5w/v% casein.
2, chemiluminescence immune assay:
Kit is prepared using embodiment 1 and detects above-mentioned blood serum sample, method is the same as embodiment 1.
3, the determination of critical value:
All samples to be tested indicate (positive percent, PP) with percent positive, and reduction formula is as follows:
PP=(sample to be tested luminous value-negative control sera average irradiance) × 100%/(positive control serum is average Luminous value-negative control sera average irradiance).
ROC curve analysis is done after obtaining the PP value of known background serum.Judge optimal critical value, diagnostic sensitivity, examine Disconnected specificity.
Interpretation of result:For this detection method, there is optimal diagnosis result when critical value is set to 7.27%.
4, sensitivity experiments:
Kit is prepared using embodiment 1 and detects 80 parts of blood serum samples, these samples are the blood collected after attacking poison Final proof product, these pigs do not carried out before carrying out attacking poison it is any immune, by calculating the sensibility of positive rate analysis method, Detection method is the same as embodiment 1.Testing result shows that the above sample 3ABC antibody has very high positive rate (97.5%).Illustrate this hair Bright kit has preferable sensibility, and the results are shown in Table 3.
The sensitivity tests of 3 chemical luminescence immune analysis reagent box of table
5, specificity experiments:
Kit is prepared using embodiment 1 and has detected pig blisters positive serum, swine fever virus positive serum and pig - 2 type positive serum of circovirus and each 30 parts of pig Seneca Valley virus negative serum, detection method is the same as embodiment 1.These blood The clear specificity for being used to evaluate Seneca Valley virus nonstructural protein 3A BC antibody chemical luminescence immune assay method.Detect pig water Blister disease positive serum, swine fever virus positive serum, the reaction of -2 type of pig circular ring virus and pig Seneca Valley virus negative serum are equal Show that kit of the invention has good specificity as a result such as the following table 4 for negative findings, fundamentally ensure that detection knot The accurate and reliability of fruit.The above serum Preliminary detection the result shows that:The Seneca Valley virus nonstructural protein 3A BC egg of selection It is white to be used as diagnostic antigen that there is good sensibility and specificity.The ROC analysis curve of 3ABC-CLIA is as shown in Figure 4.
Table 4ELISA kit specific test
6, repeated identification
5 clear serum of background are respectively done into 3 repetitions on same chemiluminescence immune assay plate, calculates and becomes between its batch Different coefficient (CV).Simultaneously by this 5 clear serum of background on 3 different luminescence immunoassay plates and the different time It does and repeats three times, calculate its variation within batch coefficient (CV).
Repeated result is (table 5) as shown in the table, and the variation within batch coefficient of the serum of 5 groups of difference infection titers is 1.83%-9.82%.Interassay coefficient of variation is 1.77%-13.15%.Therefore batch between with batch in the coefficient of variation all less than 15%, it was demonstrated that this method has repeatability well.
5 repeatability identification of table
7, the identification of stability
In order to measure the storage life of Seneca Valley virus non-structural protein antibody chemical luminescence immune assay plate, will be coated with Reaction plate be placed in 37 DEG C of environment lower 15 days.Then Seneca Valley virus positive serum is measured.As a result Seneca Valley virus is positive The luminous value of serum is 2950,000, meets the standard that experiment is set up, and the PP value of standard female serum is not above 1%.Cause This coating plate has good stability.
The above serum Preliminary detection the result shows that:The albumen of selection has good sensibility and special as diagnostic antigen Property, shows that detection kit detection time of the present invention is short, reproducible, sensibility is high, high specificity.
The foregoing is merely illustrative of the preferred embodiments of the present invention, is not intended to limit the invention, all in essence of the invention Made any modifications, equivalent replacements, and improvements etc., should all be included in the protection scope of the present invention within mind and principle.
Sequence table
<110>Lanzhou Veterinary Inst., Chinese Acedemy of Agaricultural Sciences
<120>A kind of chemical luminescence immune analysis reagent box for Seneca Valley virus nonstructural protein 3A BC antibody test
<160>2
<170>Patent-In 3.5
<210>1
<211>969
<212>DNA
<213>Seneca Valley virus
<400>1
agccccaacg agaatgatga cacccccgtc gacgaggcgt tgggtagagt tctctccccc 60
gctgcggtcg atgaggcgct tgtcgacctc actccagagg ccgacccggt tggccgtttg 120
gctattcttg ccaagctagg tcttgcccta gctgcggtca cccctggtct gataatcttg 180
gcagtgggac tctacaggta cttctctggc tctgatgcag accaagaaga aacagaaagt 240
gagggatctg tcaaggcacc caggagcgaa aatgcttatg acggcccgaa gaaaaactct 300
aagccccctg gagcactctc tctcatggaa atgcaacagc ccaacgtgga catgggcttt 360
gaggctgcgg tcgctaagaa agtggtcgtc cccattacct tcatggttcc caacagacct 420
tctgggctta cacagtccgc tcttctggtg accggccgga ccttcctaat caatgaacat 480
acatggtcca atccctcctg gaccagcttc acaatccgcg gtgaggtaca cactcgtgat 540
gagcccttcc aaacggttca tttcactcac cacggtattc ccacagatct gatgatggta 600
cgtctcggac cgggcaattc tttccctaac aatctagaca agtttggact tgaccagatg 660
ccggcacgca actcccgtgt ggttggcgtt tcgtccagtt acggaaactt cttcttctct 720
ggaaatttcc tcggatttgt tgattccatc acctctgaac aaggaactta cgcaagactc 780
tttaggtaca gggtgacgac ctacaaagga tggtgcggct cggccctggt ctgtgaggcc 840
ggtggcgtcc gacgcatcat tggcctgcat tctgctggcg ccgccggtat cggcgccggg 900
acctatatct caaaattagg actaatcaaa gccctgaaac acctcggtga acctttggcc 960
acaatgcaa 969
<210>2
<211>323
<212>PRT
<213>Seneca Valley virus
<400>2
Ser Pro Asn Glu Asn Asp Asp Thr Pro Val Asp Glu Ala Leu Gly 15
Arg Val Leu Ser Pro Ala Ala Val Asp Glu Ala Leu Val Asp Leu 30
Thr Pro Glu Ala Asp Pro Val Gly Arg Leu Ala Ile Leu Ala Lys 45
Leu Gly Leu Ala Leu Ala Ala Val Thr Pro Gly Leu Ile Ile Leu 60
Ala Val Gly Leu Tyr Arg Tyr Phe Ser Gly Ser Asp Ala Asp Gln 75
Glu Glu Thr Glu Ser Glu Gly Ser Val Lys Ala Pro Arg Ser Glu 90
Asn Ala Tyr Asp Gly Pro Lys Lys Asn Ser Lys Pro Pro Gly Ala 105
Leu Ser Leu Met Glu Met Gln Gln Pro Asn Val Asp Met Gly Phe 120
Glu Ala Ala Val Ala Lys Lys Val Val Val Pro Ile Thr Phe Met 135
Val Pro Asn Arg Pro Ser Gly Leu Thr Gln Ser Ala Leu Leu Val 150
Thr Gly Arg Thr Phe Leu Ile Asn Glu His Thr Trp Ser Asn Pro 165
Ser Trp Thr Ser Phe Thr Ile Arg Gly Glu Val His Thr Arg Asp 180
Glu Pro Phe Gln Thr Val His Phe Thr His His Gly Ile Pro Thr 195
Asp Leu Met Met Val Arg Leu Gly Pro Gly Asn Ser Phe Pro Asn 210
Asn Leu Asp Lys Phe Gly Leu Asp Gln Met Pro Ala Arg Asn Ser 225
Arg Val Val Gly Val Ser Ser Ser Tyr Gly Asn Phe Phe Phe Ser 240
Gly Asn Phe Leu Gly Phe Val Asp Ser Ile Thr Ser Glu Gln Gly 255
Thr Tyr Ala Arg Leu Phe Arg Tyr Arg Val Thr Thr Tyr Lys Gly 270
Trp Cys Gly Ser Ala Leu Val Cys Glu Ala Gly Gly Val Arg Arg 285
Ile Ile Gly Leu His Ser Ala Gly Ala Ala Gly Ile Gly Ala Gly 300
Thr Tyr Ile Ser Lys Leu Gly Leu Ile Lys Ala Leu Lys His Leu 315
Gly Glu Pro Leu Ala Thr Met Gln 323

Claims (10)

1. a kind of chemical luminescence immune analysis reagent box for Seneca Valley virus nonstructural protein 3A BC antibody test, special Sign is, the kit include Seneca Valley virus nonstructural protein 3A BC antigen coat chemiluminescence immune assay plate, Positive control serum, negative control sera, enzyme labelled antibody, sample diluting liquid, Chemoluminescent substrate, luminescence enhancer and dense Contracting cleaning solution.
2. chemical luminescence immune analysis reagent box as described in claim 1, which is characterized in that the non-knot of Seneca Valley virus Structure albumen 3ABC antigen is obtained through prokaryotic expression system, and amino acid sequence is as shown in SEQ ID NO.2.
3. chemical luminescence immune analysis reagent box as described in claim 1, which is characterized in that the Seneca Valley virus is non- The chemiluminescence immune assay plate of structural proteins 3ABC antigen coat is prepared in accordance with the following methods:
(1) preparation and coating of envelope antigen
The recombinant protein inclusion body that prokaryotic expression obtains purifies to obtain Seneca Valley virus non-through renaturation and Ni-NTA Structural proteins 3ABC, amino acid sequence are diluted to 2.5 μ g/ with carbonate buffer solution when coating as shown in SEQ ID NO.2 Ml, according in the coating to chemiluminescence immune assay plate of 100 holes μ l/, 4 DEG C of refrigerators are stood overnight;
(2) closing and preservation of chemiluminescence immune assay plate
With PBST washing 3 times, every hole is added 100 μ l and contains 5w/v% skimmed milk power and 0.01w/ chemiluminescence immune assay plate The confining liquid of v% thimerosal, 37 DEG C of closing 2h discard confining liquid, and PBST is washed 3 times, using aluminium foil bag vacuum seal, 4 DEG C of guarantors It deposits.
4. chemical luminescence immune analysis reagent box as described in claim 1, which is characterized in that the positive control serum be through The Swine serum of 14 days high infection titers after Seneca Valley virus infection;The negative control sera is that any vaccine was not immunized Healthy Swine serum.
5. chemical luminescence immune analysis reagent box as described in claim 1, which is characterized in that the enzyme labelled antibody is horseradish The rabbit-anti pig IgG secondary antibody of peroxidase labelling.
6. chemical luminescence immune analysis reagent box as described in claim 1, which is characterized in that the sample diluting liquid be containing 1w/v% trehalose, 0.01w/v% thimerosal, the 0.01M phosphate of 0.01v/v%Tween20 and 0.5w/v% casein are molten Liquid.
7. chemical luminescence immune analysis reagent box as described in claim 1, which is characterized in that the Chemoluminescent substrate For with Tris-HCl buffer, containing luminol and to the mixed liquor of iodophenol, the luminescence enhancer is to use Tris- The mixed liquor containing hydrogen peroxide and Tween20 of HCl buffer.
8. chemical luminescence immune analysis reagent box as described in claim 1, which is characterized in that the Chemoluminescent substrate For the mixed liquor with the luminol containing 0.1mmol/L of 0.05M Tris-HCl buffer and 0.1mmol/L to iodophenol, institute The luminescence enhancer stated is hydrogen peroxide containing 7.5mmol/L, the 0.005v/v% with 0.05M Tris-HCl buffer The mixed liquor of Tween20.
9. chemical luminescence immune analysis reagent box as described in claim 1, which is characterized in that the concentrated cleaning solution is 10 × PBST solution, i.e. the 0.1mol/L PBS solution containing 0.5v/v%Tween20, pH 7.4 dilute 10 times when use.
10. chemical luminescence immune analysis reagent box as described in claim 1, which is characterized in that using the kit into When row Seneca Valley virus nonstructural protein 3A BC antibody test, follow the steps below:
(1) Sample Dilution
By sample to be tested, positive control serum and negative control sera sample diluting liquid according to volume ratio 1:32 progress are dilute It releases;
(2) board-washing
The chemiluminescence immune assay plate that Seneca Valley virus nonstructural protein 3A BC antigen coat is taken out from 4 DEG C of refrigerators, beats Aluminium foil bag is opened, takes out chemiluminescence immune assay plate, with cleaning solution board-washing 3 times diluted, blotting paper is patted dry, each 3min;
(3) it is loaded
Sample to be tested, positive control serum and negative control sera after dilution is separately added into chemiluminescence immune assay plate In, every hole 100 μ L, 37 DEG C of incubation 5min;
(4) it washs
Chemiluminescence immune assay plate is taken out, blood serum sample is got rid of, is rinsed 4 times with cleaning solution, blotting paper pats dry;
(5) enzyme labelled antibody is added
The rabbit-anti pig IgG secondary antibody of the horseradish peroxidase-labeled diluted, 100 holes μ L/, 37 DEG C of work 5min are added;
(6) add substrate:
Enzyme labelled antibody is got rid of, is rinsed 4 times with cleaning solution, blotting paper pats dry, and chemiluminescent substrate and luminescence enhancer is added, and mixes It is even, it is protected from light and stands 5min;
(7) luminous value, calculating and judgement are measured:
In measuring luminous value on chemical illumination immunity analysis instrument device, all samples to be tested indicate (positive with percent positive Percent, PP), reduction formula is as follows:
PP=(sample to be tested luminous value-negative control sera average irradiance) × 100%/(positive control serum average luminescence Value-negative control sera average irradiance)
Critical value is set to 7.27%, and the positive is determined as if calculated result >=7.27%, otherwise is feminine gender.
CN201810765363.2A 2018-07-12 2018-07-12 A kind of chemical luminescence immune analysis reagent box for Seneca Valley virus nonstructural protein 3A BC antibody test Pending CN108872576A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810765363.2A CN108872576A (en) 2018-07-12 2018-07-12 A kind of chemical luminescence immune analysis reagent box for Seneca Valley virus nonstructural protein 3A BC antibody test

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810765363.2A CN108872576A (en) 2018-07-12 2018-07-12 A kind of chemical luminescence immune analysis reagent box for Seneca Valley virus nonstructural protein 3A BC antibody test

Publications (1)

Publication Number Publication Date
CN108872576A true CN108872576A (en) 2018-11-23

Family

ID=64301640

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810765363.2A Pending CN108872576A (en) 2018-07-12 2018-07-12 A kind of chemical luminescence immune analysis reagent box for Seneca Valley virus nonstructural protein 3A BC antibody test

Country Status (1)

Country Link
CN (1) CN108872576A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110196325A (en) * 2019-06-24 2019-09-03 中国动物疫病预防控制中心(农业农村部屠宰技术中心) Senecan virus diagnostic kit and test paper
CN110221064A (en) * 2019-05-23 2019-09-10 南京农业大学 Pig Seneca Valley virus ELISA antibody detection method and application
CN111273036A (en) * 2020-03-06 2020-06-12 中国农业科学院兰州兽医研究所 Monoclonal antibody competition chemiluminescence kit for detecting foot-and-mouth disease non-structural protein antibody
CN111944764A (en) * 2020-08-31 2020-11-17 信阳农林学院 Cell line for expressing suijiancai valley virus protein, construction method and application
CN112745387A (en) * 2019-10-31 2021-05-04 洛阳普泰生物技术有限公司 Anti-porcine seneca valley virus monoclonal antibody and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104478998A (en) * 2014-12-09 2015-04-01 中牧实业股份有限公司 Pig foot-and-mouth disease virus non-structural protein 3ABC antibody enzyme-linked immunosorbent assay kit
CN106596932A (en) * 2016-11-25 2017-04-26 中国农业科学院兰州兽医研究所 Chemiluminescence detection kit of swine foot-and-mouth disease 3ABC and 2C antibodies
CN107253978A (en) * 2017-08-13 2017-10-17 中牧实业股份有限公司 Sai Nika paddy virus structural protein antibody ELISA immunity detection reagents
US20180057541A1 (en) * 2016-08-23 2018-03-01 Regents Of The University Of Minnesota Senecavirus a antigens and methods of use
CN107894508A (en) * 2017-08-31 2018-04-10 中国农业科学院兰州兽医研究所 A kind of solid phase competitive ELISA kit and its application for the detection of Senecan antiviral antibody

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104478998A (en) * 2014-12-09 2015-04-01 中牧实业股份有限公司 Pig foot-and-mouth disease virus non-structural protein 3ABC antibody enzyme-linked immunosorbent assay kit
US20180057541A1 (en) * 2016-08-23 2018-03-01 Regents Of The University Of Minnesota Senecavirus a antigens and methods of use
CN106596932A (en) * 2016-11-25 2017-04-26 中国农业科学院兰州兽医研究所 Chemiluminescence detection kit of swine foot-and-mouth disease 3ABC and 2C antibodies
CN107253978A (en) * 2017-08-13 2017-10-17 中牧实业股份有限公司 Sai Nika paddy virus structural protein antibody ELISA immunity detection reagents
CN107894508A (en) * 2017-08-31 2018-04-10 中国农业科学院兰州兽医研究所 A kind of solid phase competitive ELISA kit and its application for the detection of Senecan antiviral antibody

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DVORAK CHERYL M. T.等。: "An indirect enzyme-linked immunosorbent assay for the identification of antibodies to Senecavirus A in swine.", 《BMC VETERINARY RESEARCH》 *
FAN YANG 等。: "Immunogenicity and protective efficacy of an inactivated cell culture-derived Seneca Valley virus vaccine in pigs。", 《VACCINE》 *
YANG MING 等。: "Generation and diagnostic application of monoclonal antibodies against Seneca Valley virus.", 《JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION》 *
刘存 等。: "A型塞内卡病毒病原学、流行病学和诊断研究进展。", 《猪业科学》 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110221064A (en) * 2019-05-23 2019-09-10 南京农业大学 Pig Seneca Valley virus ELISA antibody detection method and application
CN110196325A (en) * 2019-06-24 2019-09-03 中国动物疫病预防控制中心(农业农村部屠宰技术中心) Senecan virus diagnostic kit and test paper
CN112745387A (en) * 2019-10-31 2021-05-04 洛阳普泰生物技术有限公司 Anti-porcine seneca valley virus monoclonal antibody and application thereof
CN112745387B (en) * 2019-10-31 2022-11-08 洛阳普泰生物技术有限公司 Anti-porcine Seneca valley virus monoclonal antibody and application thereof
CN111273036A (en) * 2020-03-06 2020-06-12 中国农业科学院兰州兽医研究所 Monoclonal antibody competition chemiluminescence kit for detecting foot-and-mouth disease non-structural protein antibody
CN111273036B (en) * 2020-03-06 2021-06-15 中国农业科学院兰州兽医研究所 Monoclonal antibody competition chemiluminescence kit for detecting foot-and-mouth disease non-structural protein antibody
CN111944764A (en) * 2020-08-31 2020-11-17 信阳农林学院 Cell line for expressing suijiancai valley virus protein, construction method and application

Similar Documents

Publication Publication Date Title
CN108872576A (en) A kind of chemical luminescence immune analysis reagent box for Seneca Valley virus nonstructural protein 3A BC antibody test
CN108872575A (en) A kind of Seneca Valley virus nonstructural protein 3A BC antibody ELISA detection kit
CN108872574A (en) A kind of chemical luminescence immune analysis reagent box for Seneca Valley virus Structural protein VP1 antibody test
CN105527442B (en) A kind of hog cholera antibody detecting system and preparation method thereof
CN107894508A (en) A kind of solid phase competitive ELISA kit and its application for the detection of Senecan antiviral antibody
CN112574320B (en) Fusion protein antigen for diagnosing brucellosis of dog
CN109187993A (en) A kind of foot and mouth disease A-type virus sIgA antibody ELISA detection kit and its application
CN109232720A (en) A kind of O-shaped virus sIgA antibody ELISA detection kit of aftosa and its application
CN106596932A (en) Chemiluminescence detection kit of swine foot-and-mouth disease 3ABC and 2C antibodies
CN107741495A (en) A kind of double crush syndrome kit and its application for Senecan virus antigen detection
CN103487582A (en) Porcine reproductive and respiratory syndrome virus antibody competitive AlphaLISA detection kit and detection method thereof
CN106226519A (en) A kind of O type antibodies against foot-and-mouth disease virus chemiluminescence detection kit
EP4113121A1 (en) Antigen for 2019 novel coronavirus and detection use thereof
CN110221065A (en) A kind of fowl Mycoplasma synoviae indirect ELISA testing kit
CN207623349U (en) A kind of porcine pseudorabies virus antibody assay kit
CN106596966A (en) Chemiluminescent detection kit for bovine foot-and-mouth disease 3ABC antibody
CN108627645A (en) Duck tembusu virus disease E-ELISA detection kits and preparation method thereof
CN104987368A (en) Foot-and-mouth disease virus structure protein antibody ELISA kit
CN107759674A (en) A kind of Mycoplasma bovis immune-related albumen, the detection kit containing the albumen and its purposes in Mycoplasma bovis antibody test
CN103499689A (en) Competitive Alpha LISA (linked immuno sorbent assay) detection kit for porcine circovirus (PCV) 2 antibody and detection method thereof
CN109239341A (en) A kind of indirect ELISA reagent kit of ox Mannheimia haemolytica antibody test and its application
CN103063838B (en) Primer and kit for identifying foot-and-mouth disease and immunity of entry animal
CN108624713A (en) A kind of porcine pseudorabies vaccine virus differentiates the method and kit of detection with wild poison
CN105330727B (en) 1 type duck hepatitis A virus VP4 recombinant protein of one kind, ELISA kit and preparation method thereof
CN106324238A (en) Indirect ELISA kit for cat toxoplasma gondii serum antibody and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20181123

RJ01 Rejection of invention patent application after publication